tradingkey.logo
tradingkey.logo
Search

Evommune Inc

EVMN
Add to Watchlist
22.920USD
+0.165+0.73%
Close 05/15, 16:00ETQuotes delayed by 15 min
825.54MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of Evommune Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---27.50M
Net income from continuing operations
---21.67M
Operating gains losses
--349.00K
Other non-cash items
---792.00K
Change in working capital
---8.84M
-Change in prepaid expenses
---85.00K
-Change in other current liabilities
--0.00
Cash from non-recurring investing activities
Cash from operating activities
---27.50M
Investing cash flow
Net cash from continuing investing activities
--83.00K
Capital expenditures
--83.00K
Net cash flow from disposal of fixed assets
--83.00K
Net cash flow from investment products
---85.28M
Net cash flow from other investing activities
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
---85.36M
Financing cash flow
Cash flow from continuous financing activities
--117.11M
Net cash flow from debt Issuance/repayment
---87.00K
Net cash flow from common stock issuance/repurchase
--117.20M
Proceeds from stock option exercised by employees
--0.00
Net cash flow from other financing activities
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
--117.11M
Net cash flow
Beginning cash balance
--45.48M
Current period cash flow changes
--4.25M
Ending cash balance
--49.73M
Free cash flow
---27.59M
Currency unit
USD
Audit opinions
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI